117 related articles for article (PubMed ID: 24684401)
1. Notable decrease of malignant pleural effusion after treatment with sorafenib in radioiodine-refractory follicular thyroid carcinoma.
Liu M; Shen Y; Ruan M; Li M; Chen L
Thyroid; 2014 Jul; 24(7):1179-83. PubMed ID: 24684401
[TBL] [Abstract][Full Text] [Related]
2. Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib.
Shen Y; Ruan M; Luo Q; Yu Y; Lu H; Zhu R; Chen L
Thyroid; 2012 Aug; 22(8):856-60. PubMed ID: 22793259
[TBL] [Abstract][Full Text] [Related]
3. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
[TBL] [Abstract][Full Text] [Related]
4. Successful use of sorafenib after bortezomib failure in metastatic follicular thyroid cancer - a case report.
Eisner F; Schaberl-Moser R; Gerger A; Samonigg H; Pichler M
Onkologie; 2013; 36(6):368-70. PubMed ID: 23774152
[TBL] [Abstract][Full Text] [Related]
5. Partial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer.
Pitoia F; Abelleira E; Jerkovich F; Urciuoli C; Cross G
Arch Endocrinol Metab; 2015 Aug; 59(4):347-50. PubMed ID: 26331323
[TBL] [Abstract][Full Text] [Related]
6. Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Iyer P; Mayer JL; Ewig JM
Thyroid; 2014 Jan; 24(1):169-74. PubMed ID: 23544852
[TBL] [Abstract][Full Text] [Related]
7. Treatment with sorafenib in advanced thyroid cancer - a case report.
Krajewska J; Olczyk T; Roskosz J; Paliczk-Cieślik E; Smietana AK; Kaczmarek-Borowska B; Jarząb B
Endokrynol Pol; 2010; 61(5):492-6. PubMed ID: 21049464
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
10. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
11. Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Danilovic DLS; Castro G; Roitberg FSR; Vanderlei FAB; Bonani FA; Freitas RMC; Coura-Filho GB; Camargo RY; Kulcsar MA; Marui S; Hoff AO
Arch Endocrinol Metab; 2018 Jun; 62(3):370-375. PubMed ID: 29791660
[TBL] [Abstract][Full Text] [Related]
12. Use of
Oliván-Sasot P; Falgás-Lacueva M; García-Sánchez J; Vera-Pinto V; Olivas-Arroyo C; Bello-Arques P
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):116-119. PubMed ID: 27793633
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.
Hoftijzer H; Heemstra KA; Morreau H; Stokkel MP; Corssmit EP; Gelderblom H; Weijers K; Pereira AM; Huijberts M; Kapiteijn E; Romijn JA; Smit JW
Eur J Endocrinol; 2009 Dec; 161(6):923-31. PubMed ID: 19773371
[TBL] [Abstract][Full Text] [Related]
14. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis.
Shen CT; Qiu ZL; Luo QY
Endocr Relat Cancer; 2014 Apr; 21(2):253-61. PubMed ID: 24302666
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion.
Hsu KF; Hsieh CB; Duh QY; Chien CF; Li HS; Shih ML
Onkologie; 2009 Feb; 32(1-2):47-9. PubMed ID: 19209020
[TBL] [Abstract][Full Text] [Related]
17. Pituitary metastases from follicular thyroid carcinoma.
Prodam F; Pagano L; Belcastro S; Golisano G; Busti A; Samà M; Caputo M; Bellone S; Voci A; Valente G; Aimaretti G
Thyroid; 2010 Jul; 20(7):823-30. PubMed ID: 20604687
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET.
Marotta V; Ramundo V; Camera L; Del Prete M; Fonti R; Esposito R; Palmieri G; Salvatore M; Vitale M; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2013 May; 78(5):760-7. PubMed ID: 23009688
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
20. [Lenvatinib in radioiodine refractory thyroid carcinomas].
de la Fouchardiere C
Bull Cancer; 2016 Nov; 103(11):905-910. PubMed ID: 27817859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]